Allogeneic Stem Cell Transplantation
1st Edition
Published on 8. November 2002
X, 454 pages
978-1-59259-333-0 (ISBN)
Description
Internationally recognized physicians and researchers review both the basics of allogeneic stem cell transplantation and recent advances in the field, particularly as they relate to antitumor effects and graft-versus-host disease They also provide unique decision-tree analyses to guide clinicians in selecting and managing their allogeneic transplant patients. The innovations discussed cover a variety of areas, ranging from stem cell mobilization in normal donors, to indications for allogeneic transplantation other than hematologic malignancies, to the use of nonmyeloablative conditioning regimens. The authors also explore new developments in the optimal selection of unrelated allogeneic grafts (e.g., matched unrelated donor, partially mismatched family member, or umbilical cord blood), the use allogeneic peripheral blood stem cell vs marrow-derived grafts for transplantation, and the kinetics of immune reconstitution after transplantation.
More details
Other editions
New editions
Hillard M. Lazarus | Mary J. Laughlin
Allogeneic Stem Cell Transplantation
E-Book
03/2010
2nd Edition
Humana
€139.09
Available for download
Additional editions
Mary J. Laughlin | Hillard M. Lazarus
Allogeneic Stem Cell Transplantation
Clinical Research and Practice
Book
11/2003
Humana Press Inc.
€85.59
Article exhausted; check for reprint
Content
1 Hematopoietic Stem Cell Transplantation: A Historical Perspective.- 2 Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia.- 3 Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia.- 4 Chronic Myelogenous Leukemia.- 5 Allogeneic Stem Cell Transplantation for Breast Cancer.- 6 Allogeneic Transplantation for the Treatment of Multiple Myeloma.- 7 Non-Hodgkin's Lymphoma.- 8 Blood vs Marrow Allogeneic Stem Cell Transplantation.- 9 Haploidentical Stem Cell Transplantation.- 10 Umbilical Cord Blood Transplantation.- 11 Mesenchymal Stem Cells in Allogeneic Transplantation.- 12 Cytokines in Allogeneic Stem Cell Mobilization.- 13 Nonmyeloablative Allogeneic Transplantation.- 14 Recent Developments in Epidemiology and Management of Invasive Fungal Infections.- 15 Immune Recovery Following Allogeneic Blood Transplantation: Mechanisms of Immune Dysfunction.- 16 Grading and Management of Graft-vs-Host Disease.- 17 Posttransplant EBV-Associated Disease.- 18 Allogeneic Antitumor Vaccine Strategies.- 19 Donor Leukocyte Infusions.- 20 Second Hematopoietic Stem Cell Transplantation for the Treatment of Graft Failure, Graft Rejection, or Relapse.- 21 The Role of T Cell Depletion in Bone Marrow Transplantation.- 22 Minimal Residual Disease in Allogeneic Recipients.- 23 Nonhuman Primate Models of Hematopoietic Stem Cell Transplantation.- 24 In Vivo Models for the Study of Graft-vs-Host Disease and Graft-vs-Tumor Effects.- 25 Allogeneic Effector Cell Populations: Separating GVL from GVHD.- 26 Dendritic Cells: Immunobiology and Potential Use for Cancer Immunotherapy.- 27 Epilogue.
